The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3138916
WO Application Number:
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16193340.3
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Belgium (BE)
Publications:
Dates
Filing date:
25/05/2012
Grant date:
19/06/2019
EP Publication Date:
08/03/2017
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
13/08/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
19/06/2019
EP B1 Publication Date:
19/06/2019
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
24/05/2032
Lapsed By Expiration Date:
Patent Validated Date:
21/08/2019
Revocation Date:
24/10/2023
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
19/06/2019
Name:
GlaxoSmithKline Biologicals S.A.
Address:
rue de l'Institut, 89, 1330 RIXENSART, Belgium (BE)